Project Grant R03AG092302
Award Date 9/30/25
Completion Date 8/31/27
Dollars Obligated $160K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
- This federal Project Grant award of $457,112 was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The award supports research at Northwestern University to investigate a powerful cell death mechanism known as DISE (Death Induced by Survival Elimination) and its potential links to neurodegenerative diseases like Huntington's and Alzheimer's. Key objectives include understanding how overactive DISE or loss of protective mechanisms...
- This federal Project Grant award for $1,249,957.00 was provided by the National Institute on Aging (NIA), which administers the Aging Research federal grant program (CFDA 93.866). The funding will support preclinical and IND-enabling studies for a small molecule drug candidate that is designed to be disease-modifying, low-cost, and require only 6 subcutaneous injections per year for the treatment of Alzheimer's disease. The goal is to develop a new therapeutic that can improve the clearance of...
- The Project Grant award titled "ENHANCER-AAVS TO MONITOR AND RESTORE CELL-TYPE SELECTIVE INHIBITORY DEFICITS AND CIRCUIT DYSFUNCTION IN HUMANIZED ALZHEIMER'S DISEASE MODELS" was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The $1,459,072.00 award, granted to the J. David Gladstone Institutes, aims to monitor and manipulate inhibitory interneuron cell populations in mouse models to assess their contribution to...
- The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $148,050 project grant to Northwestern University to investigate sex-specific hypothalamic pathology and immune infiltration in Alzheimer's disease (AD). The project aims to utilize single-cell fixed RNA profiling to identify and evaluate cell-specific transcriptomic alterations in the AD hypothalamus, as well as explore how altered hormonal signaling may influence neuroinflammation...
- This federal Project Grant award of $509,413.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to conduct research on the role of epitranscriptomic regulation of microglial cells in the development and progression of Alzheimer's disease (AD). The project will investigate how methylation of adenosine residues in mRNA (m6A modification) and its regulatory proteins are altered in the brains of AD patients, and how these changes impact microglial function and the brain's...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,851,569.00 in funding to The Washington University to conduct research on how early brain development informs later neurodegeneration, with a focus on Alzheimer's disease. The project aims to determine if regions of the brain with high plasticity during early development are more susceptible to pathological changes later in life, and if adverse developmental conditions have...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $804,450.00 to support research conducted by the J. David Gladstone Institutes in San Francisco, CA aimed at "Targeting NELL2 and GABAergic Dysfunction to Mitigate ApoE4-Driven Pathogenesis in Alzheimer's Disease." The research will investigate how the Alzheimer's disease risk factor ApoE4 interacts with sex and aging to contribute to neuronal network hyperactivity and cognitive...
- This Project Grant award from the National Institute on Aging's Aging Research federal grant program (CFDA 93.866) provides $871,419 to the University of Washington to conduct research on the role of microglia, the brain's immune cells, in the pathogenesis of Alzheimer's disease. The research aims to characterize molecular profiles and spatial organization of microglia across the adult age spectrum, both with and without Alzheimer's disease, through single-nucleus RNA sequencing of over 5,000...
- The University of South Florida received a $3,297,926 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to develop novel biomaterials that can prevent, halt, and potentially cure Alzheimer's disease. The objective is to rationally design structurally related analogues of a lead compound that has demonstrated the ability to specifically interact with and stabilize the helical conformation of amyloid-beta (Aβ) peptides, thereby shifting the equilibrium of Aβ...
- This $426,674 federal grant award from the National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), supports research to investigate the implications of long-range mossy cell signaling and connectivity in Alzheimer's disease (AD). The project aims to identify ways to remediate the cognitive and emotional impairments associated with AD, with a focus on understanding the role of the dentate gyrus (DG) region of the hippocampus and the activity of glutamatergic mossy...